nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftibuten—Fatigue—Tamoxifen—pancreatic cancer	0.00334	0.00334	CcSEcCtD
Ceftibuten—Decreased appetite—Erlotinib—pancreatic cancer	0.00334	0.00334	CcSEcCtD
Ceftibuten—Constipation—Tamoxifen—pancreatic cancer	0.00332	0.00332	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.00331	0.00331	CcSEcCtD
Ceftibuten—Vaginal inflammation—Doxorubicin—pancreatic cancer	0.00331	0.00331	CcSEcCtD
Ceftibuten—Fatigue—Erlotinib—pancreatic cancer	0.00331	0.00331	CcSEcCtD
Ceftibuten—Flatulence—Irinotecan—pancreatic cancer	0.0033	0.0033	CcSEcCtD
Ceftibuten—Constipation—Erlotinib—pancreatic cancer	0.00328	0.00328	CcSEcCtD
Ceftibuten—Eructation—Doxorubicin—pancreatic cancer	0.00325	0.00325	CcSEcCtD
Ceftibuten—Melaena—Doxorubicin—pancreatic cancer	0.00323	0.00323	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00317	0.00317	CcSEcCtD
Ceftibuten—Anorexia—Sunitinib—pancreatic cancer	0.00317	0.00317	CcSEcCtD
Ceftibuten—Candida infection—Doxorubicin—pancreatic cancer	0.00316	0.00316	CcSEcCtD
Ceftibuten—Pancytopenia—Docetaxel—pancreatic cancer	0.00316	0.00316	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00314	0.00314	CcSEcCtD
Ceftibuten—Vaginal infection—Doxorubicin—pancreatic cancer	0.00312	0.00312	CcSEcCtD
Ceftibuten—Neutropenia—Docetaxel—pancreatic cancer	0.00311	0.00311	CcSEcCtD
Ceftibuten—Aplastic anaemia—Doxorubicin—pancreatic cancer	0.00311	0.00311	CcSEcCtD
Ceftibuten—Urticaria—Tamoxifen—pancreatic cancer	0.00308	0.00308	CcSEcCtD
Ceftibuten—Abdominal pain—Tamoxifen—pancreatic cancer	0.00307	0.00307	CcSEcCtD
Ceftibuten—Body temperature increased—Erlotinib—pancreatic cancer	0.00303	0.00303	CcSEcCtD
Ceftibuten—Abdominal pain—Erlotinib—pancreatic cancer	0.00303	0.00303	CcSEcCtD
Ceftibuten—Insomnia—Sunitinib—pancreatic cancer	0.003	0.003	CcSEcCtD
Ceftibuten—Paraesthesia—Sunitinib—pancreatic cancer	0.00298	0.00298	CcSEcCtD
Ceftibuten—Dyspnoea—Sunitinib—pancreatic cancer	0.00296	0.00296	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.00294	0.00294	CcSEcCtD
Ceftibuten—Dyspepsia—Sunitinib—pancreatic cancer	0.00292	0.00292	CcSEcCtD
Ceftibuten—Renal failure—Docetaxel—pancreatic cancer	0.00292	0.00292	CcSEcCtD
Ceftibuten—Jaundice—Docetaxel—pancreatic cancer	0.00289	0.00289	CcSEcCtD
Ceftibuten—Decreased appetite—Sunitinib—pancreatic cancer	0.00289	0.00289	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00287	0.00287	CcSEcCtD
Ceftibuten—Fatigue—Sunitinib—pancreatic cancer	0.00286	0.00286	CcSEcCtD
Ceftibuten—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00286	0.00286	CcSEcCtD
Ceftibuten—Constipation—Sunitinib—pancreatic cancer	0.00284	0.00284	CcSEcCtD
Ceftibuten—Asthenia—Tamoxifen—pancreatic cancer	0.00278	0.00278	CcSEcCtD
Ceftibuten—Convulsion—Fluorouracil—pancreatic cancer	0.00278	0.00278	CcSEcCtD
Ceftibuten—Agranulocytosis—Docetaxel—pancreatic cancer	0.00277	0.00277	CcSEcCtD
Ceftibuten—Asthenia—Erlotinib—pancreatic cancer	0.00275	0.00275	CcSEcCtD
Ceftibuten—Pruritus—Tamoxifen—pancreatic cancer	0.00274	0.00274	CcSEcCtD
Ceftibuten—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00274	0.00274	CcSEcCtD
Ceftibuten—Renal impairment—Epirubicin—pancreatic cancer	0.00273	0.00273	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00272	0.00272	CcSEcCtD
Ceftibuten—Pruritus—Erlotinib—pancreatic cancer	0.00272	0.00272	CcSEcCtD
Ceftibuten—Haemoglobin—Docetaxel—pancreatic cancer	0.00268	0.00268	CcSEcCtD
Ceftibuten—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00267	0.00267	CcSEcCtD
Ceftibuten—Haemorrhage—Docetaxel—pancreatic cancer	0.00266	0.00266	CcSEcCtD
Ceftibuten—Diarrhoea—Tamoxifen—pancreatic cancer	0.00265	0.00265	CcSEcCtD
Ceftibuten—Abdominal pain—Sunitinib—pancreatic cancer	0.00263	0.00263	CcSEcCtD
Ceftibuten—Body temperature increased—Sunitinib—pancreatic cancer	0.00263	0.00263	CcSEcCtD
Ceftibuten—Diarrhoea—Erlotinib—pancreatic cancer	0.00263	0.00263	CcSEcCtD
Ceftibuten—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00262	0.00262	CcSEcCtD
Ceftibuten—Anorexia—Irinotecan—pancreatic cancer	0.00261	0.00261	CcSEcCtD
Ceftibuten—Dizziness—Tamoxifen—pancreatic cancer	0.00256	0.00256	CcSEcCtD
Ceftibuten—Anorexia—Gemcitabine—pancreatic cancer	0.00254	0.00254	CcSEcCtD
Ceftibuten—Dizziness—Erlotinib—pancreatic cancer	0.00254	0.00254	CcSEcCtD
Ceftibuten—Renal impairment—Doxorubicin—pancreatic cancer	0.00252	0.00252	CcSEcCtD
Ceftibuten—Erythema multiforme—Docetaxel—pancreatic cancer	0.00252	0.00252	CcSEcCtD
Ceftibuten—Anorexia—Fluorouracil—pancreatic cancer	0.0025	0.0025	CcSEcCtD
Ceftibuten—Insomnia—Irinotecan—pancreatic cancer	0.00248	0.00248	CcSEcCtD
Ceftibuten—Vomiting—Tamoxifen—pancreatic cancer	0.00247	0.00247	CcSEcCtD
Ceftibuten—Paraesthesia—Irinotecan—pancreatic cancer	0.00246	0.00246	CcSEcCtD
Ceftibuten—Hypersensitivity—Sunitinib—pancreatic cancer	0.00245	0.00245	CcSEcCtD
Ceftibuten—Rash—Tamoxifen—pancreatic cancer	0.00245	0.00245	CcSEcCtD
Ceftibuten—Dermatitis—Tamoxifen—pancreatic cancer	0.00244	0.00244	CcSEcCtD
Ceftibuten—Vomiting—Erlotinib—pancreatic cancer	0.00244	0.00244	CcSEcCtD
Ceftibuten—Dyspnoea—Irinotecan—pancreatic cancer	0.00244	0.00244	CcSEcCtD
Ceftibuten—Somnolence—Irinotecan—pancreatic cancer	0.00243	0.00243	CcSEcCtD
Ceftibuten—Headache—Tamoxifen—pancreatic cancer	0.00243	0.00243	CcSEcCtD
Ceftibuten—Rash—Erlotinib—pancreatic cancer	0.00242	0.00242	CcSEcCtD
Ceftibuten—Dermatitis—Erlotinib—pancreatic cancer	0.00242	0.00242	CcSEcCtD
Ceftibuten—Dehydration—Epirubicin—pancreatic cancer	0.00241	0.00241	CcSEcCtD
Ceftibuten—Insomnia—Gemcitabine—pancreatic cancer	0.00241	0.00241	CcSEcCtD
Ceftibuten—Dyspepsia—Irinotecan—pancreatic cancer	0.00241	0.00241	CcSEcCtD
Ceftibuten—Headache—Erlotinib—pancreatic cancer	0.0024	0.0024	CcSEcCtD
Ceftibuten—Paraesthesia—Gemcitabine—pancreatic cancer	0.00239	0.00239	CcSEcCtD
Ceftibuten—Chills—Docetaxel—pancreatic cancer	0.00239	0.00239	CcSEcCtD
Ceftibuten—Asthenia—Sunitinib—pancreatic cancer	0.00238	0.00238	CcSEcCtD
Ceftibuten—Decreased appetite—Irinotecan—pancreatic cancer	0.00238	0.00238	CcSEcCtD
Ceftibuten—Dyspnoea—Gemcitabine—pancreatic cancer	0.00238	0.00238	CcSEcCtD
Ceftibuten—Insomnia—Fluorouracil—pancreatic cancer	0.00237	0.00237	CcSEcCtD
Ceftibuten—Somnolence—Gemcitabine—pancreatic cancer	0.00237	0.00237	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00236	0.00236	CcSEcCtD
Ceftibuten—Fatigue—Irinotecan—pancreatic cancer	0.00236	0.00236	CcSEcCtD
Ceftibuten—Paraesthesia—Fluorouracil—pancreatic cancer	0.00235	0.00235	CcSEcCtD
Ceftibuten—Pruritus—Sunitinib—pancreatic cancer	0.00235	0.00235	CcSEcCtD
Ceftibuten—Constipation—Irinotecan—pancreatic cancer	0.00234	0.00234	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.00234	0.00234	CcSEcCtD
Ceftibuten—Dyspnoea—Fluorouracil—pancreatic cancer	0.00234	0.00234	CcSEcCtD
Ceftibuten—Somnolence—Fluorouracil—pancreatic cancer	0.00233	0.00233	CcSEcCtD
Ceftibuten—Decreased appetite—Gemcitabine—pancreatic cancer	0.00232	0.00232	CcSEcCtD
Ceftibuten—Dyspepsia—Fluorouracil—pancreatic cancer	0.00231	0.00231	CcSEcCtD
Ceftibuten—Nausea—Tamoxifen—pancreatic cancer	0.0023	0.0023	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.0023	0.0023	CcSEcCtD
Ceftibuten—Fatigue—Gemcitabine—pancreatic cancer	0.0023	0.0023	CcSEcCtD
Ceftibuten—Constipation—Gemcitabine—pancreatic cancer	0.00228	0.00228	CcSEcCtD
Ceftibuten—Nausea—Erlotinib—pancreatic cancer	0.00228	0.00228	CcSEcCtD
Ceftibuten—Decreased appetite—Fluorouracil—pancreatic cancer	0.00228	0.00228	CcSEcCtD
Ceftibuten—Diarrhoea—Sunitinib—pancreatic cancer	0.00227	0.00227	CcSEcCtD
Ceftibuten—Dysgeusia—Docetaxel—pancreatic cancer	0.00227	0.00227	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00226	0.00226	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00224	0.00224	CcSEcCtD
Ceftibuten—Dehydration—Doxorubicin—pancreatic cancer	0.00223	0.00223	CcSEcCtD
Ceftibuten—Dizziness—Sunitinib—pancreatic cancer	0.0022	0.0022	CcSEcCtD
Ceftibuten—Abdominal pain—Irinotecan—pancreatic cancer	0.00216	0.00216	CcSEcCtD
Ceftibuten—Body temperature increased—Irinotecan—pancreatic cancer	0.00216	0.00216	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.00216	0.00216	CcSEcCtD
Ceftibuten—Pancytopenia—Epirubicin—pancreatic cancer	0.00213	0.00213	CcSEcCtD
Ceftibuten—Vomiting—Sunitinib—pancreatic cancer	0.00211	0.00211	CcSEcCtD
Ceftibuten—Body temperature increased—Gemcitabine—pancreatic cancer	0.00211	0.00211	CcSEcCtD
Ceftibuten—Dysuria—Epirubicin—pancreatic cancer	0.0021	0.0021	CcSEcCtD
Ceftibuten—Neutropenia—Epirubicin—pancreatic cancer	0.0021	0.0021	CcSEcCtD
Ceftibuten—Rash—Sunitinib—pancreatic cancer	0.00209	0.00209	CcSEcCtD
Ceftibuten—Dermatitis—Sunitinib—pancreatic cancer	0.00209	0.00209	CcSEcCtD
Ceftibuten—Urticaria—Fluorouracil—pancreatic cancer	0.00208	0.00208	CcSEcCtD
Ceftibuten—Headache—Sunitinib—pancreatic cancer	0.00208	0.00208	CcSEcCtD
Ceftibuten—Body temperature increased—Fluorouracil—pancreatic cancer	0.00207	0.00207	CcSEcCtD
Ceftibuten—Hypersensitivity—Irinotecan—pancreatic cancer	0.00202	0.00202	CcSEcCtD
Ceftibuten—Convulsion—Docetaxel—pancreatic cancer	0.00201	0.00201	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.00198	0.00198	CcSEcCtD
Ceftibuten—Nausea—Sunitinib—pancreatic cancer	0.00197	0.00197	CcSEcCtD
Ceftibuten—Pancytopenia—Doxorubicin—pancreatic cancer	0.00197	0.00197	CcSEcCtD
Ceftibuten—Renal failure—Epirubicin—pancreatic cancer	0.00197	0.00197	CcSEcCtD
Ceftibuten—Asthenia—Irinotecan—pancreatic cancer	0.00196	0.00196	CcSEcCtD
Ceftibuten—Jaundice—Epirubicin—pancreatic cancer	0.00195	0.00195	CcSEcCtD
Ceftibuten—Neutropenia—Doxorubicin—pancreatic cancer	0.00194	0.00194	CcSEcCtD
Ceftibuten—Dysuria—Doxorubicin—pancreatic cancer	0.00194	0.00194	CcSEcCtD
Ceftibuten—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00193	0.00193	CcSEcCtD
Ceftibuten—Dry mouth—Docetaxel—pancreatic cancer	0.00193	0.00193	CcSEcCtD
Ceftibuten—Asthenia—Gemcitabine—pancreatic cancer	0.00191	0.00191	CcSEcCtD
Ceftibuten—Haematuria—Epirubicin—pancreatic cancer	0.00191	0.00191	CcSEcCtD
Ceftibuten—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00189	0.00189	CcSEcCtD
Ceftibuten—Pruritus—Gemcitabine—pancreatic cancer	0.00189	0.00189	CcSEcCtD
Ceftibuten—Diarrhoea—Irinotecan—pancreatic cancer	0.00187	0.00187	CcSEcCtD
Ceftibuten—Agranulocytosis—Epirubicin—pancreatic cancer	0.00187	0.00187	CcSEcCtD
Ceftibuten—Pruritus—Fluorouracil—pancreatic cancer	0.00185	0.00185	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.00184	0.00184	CcSEcCtD
Ceftibuten—Diarrhoea—Gemcitabine—pancreatic cancer	0.00182	0.00182	CcSEcCtD
Ceftibuten—Renal failure—Doxorubicin—pancreatic cancer	0.00182	0.00182	CcSEcCtD
Ceftibuten—Dizziness—Irinotecan—pancreatic cancer	0.00181	0.00181	CcSEcCtD
Ceftibuten—Haemoglobin—Epirubicin—pancreatic cancer	0.00181	0.00181	CcSEcCtD
Ceftibuten—Jaundice—Doxorubicin—pancreatic cancer	0.0018	0.0018	CcSEcCtD
Ceftibuten—Anorexia—Docetaxel—pancreatic cancer	0.0018	0.0018	CcSEcCtD
Ceftibuten—Haemorrhage—Epirubicin—pancreatic cancer	0.0018	0.0018	CcSEcCtD
Ceftibuten—Diarrhoea—Fluorouracil—pancreatic cancer	0.00179	0.00179	CcSEcCtD
Ceftibuten—Haematuria—Doxorubicin—pancreatic cancer	0.00176	0.00176	CcSEcCtD
Ceftibuten—Vomiting—Irinotecan—pancreatic cancer	0.00174	0.00174	CcSEcCtD
Ceftibuten—Dizziness—Fluorouracil—pancreatic cancer	0.00173	0.00173	CcSEcCtD
Ceftibuten—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00173	0.00173	CcSEcCtD
Ceftibuten—Rash—Irinotecan—pancreatic cancer	0.00173	0.00173	CcSEcCtD
Ceftibuten—Dermatitis—Irinotecan—pancreatic cancer	0.00172	0.00172	CcSEcCtD
Ceftibuten—Headache—Irinotecan—pancreatic cancer	0.00171	0.00171	CcSEcCtD
Ceftibuten—Insomnia—Docetaxel—pancreatic cancer	0.00171	0.00171	CcSEcCtD
Ceftibuten—Paraesthesia—Docetaxel—pancreatic cancer	0.0017	0.0017	CcSEcCtD
Ceftibuten—Erythema multiforme—Epirubicin—pancreatic cancer	0.0017	0.0017	CcSEcCtD
Ceftibuten—Vomiting—Gemcitabine—pancreatic cancer	0.00169	0.00169	CcSEcCtD
Ceftibuten—Dyspnoea—Docetaxel—pancreatic cancer	0.00169	0.00169	CcSEcCtD
Ceftibuten—Somnolence—Docetaxel—pancreatic cancer	0.00168	0.00168	CcSEcCtD
Ceftibuten—Rash—Gemcitabine—pancreatic cancer	0.00168	0.00168	CcSEcCtD
Ceftibuten—Dermatitis—Gemcitabine—pancreatic cancer	0.00168	0.00168	CcSEcCtD
Ceftibuten—Haemoglobin—Doxorubicin—pancreatic cancer	0.00167	0.00167	CcSEcCtD
Ceftibuten—Headache—Gemcitabine—pancreatic cancer	0.00167	0.00167	CcSEcCtD
Ceftibuten—Vomiting—Fluorouracil—pancreatic cancer	0.00167	0.00167	CcSEcCtD
Ceftibuten—Dyspepsia—Docetaxel—pancreatic cancer	0.00167	0.00167	CcSEcCtD
Ceftibuten—Haemorrhage—Doxorubicin—pancreatic cancer	0.00166	0.00166	CcSEcCtD
Ceftibuten—Rash—Fluorouracil—pancreatic cancer	0.00165	0.00165	CcSEcCtD
Ceftibuten—Dermatitis—Fluorouracil—pancreatic cancer	0.00165	0.00165	CcSEcCtD
Ceftibuten—Decreased appetite—Docetaxel—pancreatic cancer	0.00164	0.00164	CcSEcCtD
Ceftibuten—Headache—Fluorouracil—pancreatic cancer	0.00164	0.00164	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00163	0.00163	CcSEcCtD
Ceftibuten—Fatigue—Docetaxel—pancreatic cancer	0.00163	0.00163	CcSEcCtD
Ceftibuten—Nausea—Irinotecan—pancreatic cancer	0.00163	0.00163	CcSEcCtD
Ceftibuten—Constipation—Docetaxel—pancreatic cancer	0.00162	0.00162	CcSEcCtD
Ceftibuten—Chills—Epirubicin—pancreatic cancer	0.00161	0.00161	CcSEcCtD
Ceftibuten—Nausea—Gemcitabine—pancreatic cancer	0.00158	0.00158	CcSEcCtD
Ceftibuten—Erythema multiforme—Doxorubicin—pancreatic cancer	0.00157	0.00157	CcSEcCtD
Ceftibuten—Nausea—Fluorouracil—pancreatic cancer	0.00156	0.00156	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Ceftibuten—Flatulence—Epirubicin—pancreatic cancer	0.00154	0.00154	CcSEcCtD
Ceftibuten—Dysgeusia—Epirubicin—pancreatic cancer	0.00153	0.00153	CcSEcCtD
Ceftibuten—Abdominal pain—Docetaxel—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Ceftibuten—Body temperature increased—Docetaxel—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Ceftibuten—Chills—Doxorubicin—pancreatic cancer	0.00149	0.00149	CcSEcCtD
Ceftibuten—Agitation—Epirubicin—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Ceftibuten—Flatulence—Doxorubicin—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Ceftibuten—Dysgeusia—Doxorubicin—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Ceftibuten—Hypersensitivity—Docetaxel—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Ceftibuten—Asthenia—Docetaxel—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Ceftibuten—Convulsion—Epirubicin—pancreatic cancer	0.00135	0.00135	CcSEcCtD
Ceftibuten—Pruritus—Docetaxel—pancreatic cancer	0.00134	0.00134	CcSEcCtD
Ceftibuten—Agitation—Doxorubicin—pancreatic cancer	0.00133	0.00133	CcSEcCtD
Ceftibuten—Dry mouth—Epirubicin—pancreatic cancer	0.0013	0.0013	CcSEcCtD
Ceftibuten—Diarrhoea—Docetaxel—pancreatic cancer	0.00129	0.00129	CcSEcCtD
Ceftibuten—Anaphylactic shock—Epirubicin—pancreatic cancer	0.00128	0.00128	CcSEcCtD
Ceftibuten—Convulsion—Doxorubicin—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Ceftibuten—Dizziness—Docetaxel—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Ceftibuten—Anorexia—Epirubicin—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Ceftibuten—Dry mouth—Doxorubicin—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Ceftibuten—Vomiting—Docetaxel—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Ceftibuten—Rash—Docetaxel—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Ceftibuten—Dermatitis—Docetaxel—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Ceftibuten—Headache—Docetaxel—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Ceftibuten—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.00118	0.00118	CcSEcCtD
Ceftibuten—Insomnia—Epirubicin—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Ceftibuten—Paraesthesia—Epirubicin—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Ceftibuten—Dyspnoea—Epirubicin—pancreatic cancer	0.00114	0.00114	CcSEcCtD
Ceftibuten—Somnolence—Epirubicin—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Ceftibuten—Anorexia—Doxorubicin—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Ceftibuten—Nausea—Docetaxel—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Ceftibuten—Dyspepsia—Epirubicin—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Ceftibuten—Decreased appetite—Epirubicin—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Ceftibuten—Fatigue—Epirubicin—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Ceftibuten—Constipation—Epirubicin—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Ceftibuten—Insomnia—Doxorubicin—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Ceftibuten—Paraesthesia—Doxorubicin—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Ceftibuten—Dyspnoea—Doxorubicin—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Ceftibuten—Somnolence—Doxorubicin—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Ceftibuten—Dyspepsia—Doxorubicin—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Ceftibuten—Decreased appetite—Doxorubicin—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Ceftibuten—Fatigue—Doxorubicin—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Ceftibuten—Urticaria—Epirubicin—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Ceftibuten—Constipation—Doxorubicin—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Ceftibuten—Abdominal pain—Epirubicin—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Ceftibuten—Body temperature increased—Epirubicin—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000965	0.000965	CcSEcCtD
Ceftibuten—Hypersensitivity—Epirubicin—pancreatic cancer	0.00094	0.00094	CcSEcCtD
Ceftibuten—Urticaria—Doxorubicin—pancreatic cancer	0.000938	0.000938	CcSEcCtD
Ceftibuten—Body temperature increased—Doxorubicin—pancreatic cancer	0.000933	0.000933	CcSEcCtD
Ceftibuten—Abdominal pain—Doxorubicin—pancreatic cancer	0.000933	0.000933	CcSEcCtD
Ceftibuten—Asthenia—Epirubicin—pancreatic cancer	0.000915	0.000915	CcSEcCtD
Ceftibuten—Pruritus—Epirubicin—pancreatic cancer	0.000903	0.000903	CcSEcCtD
Ceftibuten—Diarrhoea—Epirubicin—pancreatic cancer	0.000873	0.000873	CcSEcCtD
Ceftibuten—Hypersensitivity—Doxorubicin—pancreatic cancer	0.00087	0.00087	CcSEcCtD
Ceftibuten—Asthenia—Doxorubicin—pancreatic cancer	0.000847	0.000847	CcSEcCtD
Ceftibuten—Dizziness—Epirubicin—pancreatic cancer	0.000844	0.000844	CcSEcCtD
Ceftibuten—Pruritus—Doxorubicin—pancreatic cancer	0.000835	0.000835	CcSEcCtD
Ceftibuten—Vomiting—Epirubicin—pancreatic cancer	0.000811	0.000811	CcSEcCtD
Ceftibuten—Diarrhoea—Doxorubicin—pancreatic cancer	0.000808	0.000808	CcSEcCtD
Ceftibuten—Rash—Epirubicin—pancreatic cancer	0.000805	0.000805	CcSEcCtD
Ceftibuten—Dermatitis—Epirubicin—pancreatic cancer	0.000804	0.000804	CcSEcCtD
Ceftibuten—Headache—Epirubicin—pancreatic cancer	0.000799	0.000799	CcSEcCtD
Ceftibuten—Dizziness—Doxorubicin—pancreatic cancer	0.000781	0.000781	CcSEcCtD
Ceftibuten—Nausea—Epirubicin—pancreatic cancer	0.000758	0.000758	CcSEcCtD
Ceftibuten—Vomiting—Doxorubicin—pancreatic cancer	0.000751	0.000751	CcSEcCtD
Ceftibuten—Rash—Doxorubicin—pancreatic cancer	0.000744	0.000744	CcSEcCtD
Ceftibuten—Dermatitis—Doxorubicin—pancreatic cancer	0.000744	0.000744	CcSEcCtD
Ceftibuten—Headache—Doxorubicin—pancreatic cancer	0.00074	0.00074	CcSEcCtD
Ceftibuten—Nausea—Doxorubicin—pancreatic cancer	0.000701	0.000701	CcSEcCtD
